Solara Active Pharma Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Solara Active Pharma Sciences Limited has submitted its financial results for the quarter/half-year ended September 30, 2025 to NSE. The announcement is a routine regulatory filing covering the specified period. No specific revenue, profit, or margin figures were disclosed in the headline text. Investors should refer to the detailed results document or PDF attachment for actual numbers and segment performance.
This is a standard compliance filing; expect the company's Q2/H1 FY26 results to be available shortly for review. The actual stock impact will depend on the numbers within the filed results, which are not visible from this announcement summary alone.